Presentation of our work at ESGCT 2026
ART-TG
2 days ago
1 min read
Our lab was presenting our work at the annual meeting of the European Society of Cell and Gene Therapy in Hamburg. We presented the development of a production process for the TREM2 lentiviral vector (Chabon et al. P0879) and the preclinical biosafety and biodistribution study for a bi-functional vector for the gene therapy of sickle cell disease (Tran et al. P0713)






Comments